GlucoRelay — Privacy Policy & Terms of Use
Effective date: August 5, 2026 | Last updated: August 5, 2026
This document contains both the Privacy Policy and the Terms of Use for GlucoRelay. Please read both sections carefully before using the App. Above all, please read the Medical Disclaimer in Part II: GlucoRelay is not a medical device and must never replace your primary CGM app, receiver, or blood glucose meter.
Part I — Privacy Policy
1. Introduction
This Privacy Policy explains how GlucoRelay ("the App"), developed and published by Approve The Move ("we", "us", "our", or "the developer"), handles information when you ("you" or "the user") download, install, or use the App on any supported device.
We are committed to protecting your privacy. This policy applies to all versions of GlucoRelay, including TestFlight beta builds and any future App Store releases.
By downloading, installing, or using GlucoRelay, you acknowledge that you have read, understood, and agree to the practices described in this policy. If you do not agree, please do not use the App and remove it from your device.
2. Overview
GlucoRelay is an iPhone dashboard for continuous glucose monitor (CGM) data. It connects to cloud services you already use with your CGM provider and displays the readings. We do not operate any servers and do not collect your personal data. We do not use analytics, tracking, advertising frameworks, or telemetry of any kind. Your glucose data flows directly between your device and the CGM provider you choose; it never passes through infrastructure we operate, because we operate none.
3. Data We Access
- Glucose readings — value, trend, timestamp — from the CGM provider you select (Dexcom, FreeStyle LibreLinkUp, Medtronic CareLink, Nightscout, Medtrum EasyView, or Apple Health).
- Device status when available from the source (pump battery, reservoir level, sensor life, insulin-on-board).
- Apple Health blood glucose samples, only if you grant HealthKit access.
4. Data Storage
- On your device. Glucose data, settings, and preferences are stored locally on your iPhone and Apple Watch. GlucoRelay does not keep your glucose history in a private iCloud container; the only time data leaves your device through iCloud is the optional Follower Sharing feature described below.
- Sign-in credentials for the CGM source you connect — which, depending on the provider, includes your account password as well as any session tokens — are stored in the iOS Keychain, Apple's encrypted credential storage. They stay on your device and are sent only to your CGM provider's own service to sign in; they are never sent to us. Some providers (such as Dexcom Share and LibreLinkUp) require the app to re-authenticate with your password when a session expires, which is why the password itself is retained.
- No server of ours. GlucoRelay does not operate any backend infrastructure. Data flows directly between your device and your CGM provider's cloud service.
- Calendar (optional, CarPlay). If you enable the CarPlay calendar feature, GlucoRelay writes your latest glucose readings into a dedicated on-device "GlucoRelay" calendar so they can appear on CarPlay. It uses write-only calendar access, prefers a local (non-iCloud) calendar, and never reads your other calendar events.
5. Follower Sharing (Optional)
If you enable Follower Sharing, your glucose readings and a display name you set are uploaded to Apple's CloudKit public database under an 8-character share code. Access is protected by the secrecy of that code — anyone who has the code can read what you share, so treat it like a password and only give it to people you trust. Shared readings are set to expire after about 24 hours and are cleaned up periodically; because there is no server we run, cleanup happens opportunistically during later uploads rather than at an exact time. Stopping sharing deactivates your code so no new readings are published. You can also delete shared data sooner by turning the feature off and removing the app.
6. Data We Do NOT Collect
- No personal information (name, email, phone)
- No analytics, tracking, or advertising frameworks
- No telemetry
- No data sold or shared with third parties (your CGM sign-in credentials go only to your own CGM provider; see Section 4)
We do not sell, rent, or trade any personal information — we never possess it. There is no personal data in our hands to sell, rent, trade, or lose.
7. Third-Party Services
GlucoRelay connects only to the CGM cloud service you choose, operated by its respective company (Dexcom, Abbott/FreeStyle LibreLinkUp, Medtronic CareLink, Medtrum), or to your own Nightscout server if you configure one. Your use of those services is governed by their own privacy policies and terms, which we do not control. GlucoRelay only reads data and never writes or modifies your CGM data.
8. Debug Reports (TestFlight)
If you use the “Send Feedback” feature, a debug report is generated containing device info, connection status, and recent glucose readings. This report is shared only when you explicitly choose to send it — nothing is ever sent automatically. Passwords and authentication tokens are never included.
9. Children's Privacy
GlucoRelay may be used by parents to monitor their children's glucose levels. The App does not collect any personal information from children or from any user of any age. Because no personal information is collected from anyone, we do not knowingly (or unknowingly) collect personal information from children under 13 (COPPA, United States) or process personal data of minors under the applicable age of digital consent (GDPR, EEA). Parents and guardians can allow children to use GlucoRelay knowing that no personal information is collected, stored, or shared by us — while keeping in mind the Medical Disclaimer in Part II, which applies equally when the App is used to view a child's readings.
10. Your Rights Under Applicable Laws
We respect and support the privacy rights granted to individuals under applicable data protection legislation worldwide. Because we hold no personal data about you, most of these rights are satisfied by default — your data lives on your device, in your iOS Keychain, and (only if you enable Follower Sharing) in Apple's CloudKit under your control.
10.1 Controls Available to You
- You can disconnect from any CGM source at any time, which removes stored session tokens.
- You can delete the App to remove all locally stored data, including Keychain credentials.
- You can revoke HealthKit access in iOS Settings at any time.
- You can stop Follower Sharing at any time, which deactivates your share code.
10.2 European Economic Area (GDPR)
If you are located in the EEA, the United Kingdom, or Switzerland, the General Data Protection Regulation (GDPR) and equivalent local laws grant you rights of access, rectification, erasure, restriction of processing, data portability, objection, and withdrawal of consent. Since we do not collect, store, or process any personal data, there is no data for us to provide, correct, restrict, delete, port, or cease processing. All exercise of these rights is in your own hands: delete the App, disconnect a CGM source, revoke HealthKit access, or stop Follower Sharing. If you believe we hold data about you in error, please contact us and we will investigate promptly.
Data controller: Approve The Move (contact details in Section 36).
10.3 California (CCPA / CPRA)
If you are a California resident, the CCPA as amended by the CPRA grants you rights to know, delete, correct, opt out of sale or sharing, and non-discrimination. We do not collect, sell, or share personal information. We have not sold or shared personal information of any consumer in the preceding 12 months, nor do we intend to do so. "Do Not Track" signals and Global Privacy Control (GPC) are respected by default, as the App does not track users in any capacity.
10.4 Qatar & Middle East
If you are located in Qatar or other Gulf Cooperation Council (GCC) states, we comply with applicable data protection laws, including Qatar's Law No. 13 of 2016 on Personal Data Privacy. As we do not collect personal data, no registration with the Compliance and Data Protection Department is required.
10.5 Other Jurisdictions
Regardless of your location, the same principle applies: we do not collect personal data, so there is no data held by us to exercise rights over. If your local laws grant you additional privacy rights, please contact us and we will cooperate fully.
11. Data Security
Although we do not collect or store personal data on any server, the App is built to protect the data on your device:
- Keychain-protected credentials — CGM sign-in credentials are stored in the iOS Keychain, Apple's encrypted credential storage, and transmitted only to your CGM provider's own service over encrypted (TLS) connections.
- Sandboxed storage — On-device data is stored within the App's iOS sandbox, isolated from other apps and protected by the operating system.
- No server of ours to breach — Because we operate no backend, there is no server of ours holding your data that could be breached.
Honesty requires us to add: no method of electronic storage or transmission is 100% secure. The security of your CGM provider's cloud service, Apple's CloudKit, your Apple ID, and your device itself is outside our control. To the maximum extent permitted by applicable law, we are not liable for security incidents arising from circumstances beyond our reasonable control, including breaches of third-party services or of your own device or accounts.
Part II — Terms of Use
12. Acceptance of Terms
By downloading, installing, accessing, or using GlucoRelay, you agree to be bound by these Terms of Use. If you do not agree to these terms, do not use the App and remove it from your device.
These terms constitute a legally binding agreement between you and Approve The Move ("we", "us", "our") governing your use of the App.
13. Medical Disclaimer & Intended Use
GLUCORELAY IS NOT A MEDICAL DEVICE. IT HAS NOT BEEN CLEARED, APPROVED, OR CERTIFIED BY THE FDA OR ANY OTHER REGULATORY BODY IN ANY COUNTRY. IT IS AN INFORMATIONAL, SECONDARY DISPLAY ONLY.
You acknowledge and agree that:
- Secondary display only — GlucoRelay is a passive viewer of data already produced by your CGM system and its manufacturer's cloud service. It does not measure, generate, calibrate, or validate glucose values.
- Never a replacement for your primary device — GlucoRelay must NEVER be used as a replacement for your primary CGM app, CGM receiver, or blood glucose meter. Always keep your primary device available and functioning.
- All treatment decisions belong to your primary device and your doctor — ALL treatment decisions — including insulin dosing and the treatment of hypoglycemia or hyperglycemia — must be based on readings from your primary CGM device or blood glucose meter and on the advice of qualified healthcare professionals, never on GlucoRelay alone.
- Data may be wrong, stale, or missing — Readings shown in GlucoRelay may be delayed, out of date, incomplete, or inaccurate due to factors outside our control, including the CGM provider's cloud service, your network connection, and iOS itself.
14. Alerts & Notifications Are Best-Effort
ALERTS AND NOTIFICATIONS FROM GLUCORELAY ARE PROVIDED ON A BEST-EFFORT BASIS ONLY AND MUST NOT BE RELIED UPON FOR YOUR SAFETY.
Notifications can fail entirely or arrive late for many reasons beyond our control, including: loss of internet connectivity; outages or changes at your CGM provider's cloud service; iOS background-execution, Focus, Do Not Disturb, Low Power Mode, or battery restrictions; notification settings on your device; and the App being terminated by the system or by you. You agree to keep the alarms on your primary CGM device or app enabled at all times and never to depend on GlucoRelay as your only source of glucose alerts.
15. Not an Emergency Service
GlucoRelay is not an emergency notification, monitoring, or response service. In a medical emergency, contact your local emergency services immediately. Do not wait for, or rely on, any reading or alert from the App.
16. Assumption of Risk
You expressly acknowledge and accept the risks described in Sections 13, 14, and 15, and you agree that:
- Any use of GlucoRelay for any medical or health-related purpose is at your sole risk.
- You understand that readings and alerts may be delayed, missing, or wrong, and you accept the consequences of that possibility by choosing to use a secondary display.
- You remain solely responsible for your (or, where you supervise a child's use, your child's) diabetes management, in consultation with qualified healthcare professionals.
- If you share readings with followers, you accept that their displays are subject to the same limitations (see Section 21).
This section does not exclude liability that cannot be excluded under applicable law; it records your informed acceptance of the inherent, honestly disclosed limits of a secondary display.
17. No Medical or Professional Advice
Nothing displayed in or communicated through GlucoRelay — readings, trends, charts, statistics, alerts, or any other content — constitutes medical, clinical, or other professional advice, diagnosis, or treatment. Always seek the advice of your physician, diabetes care team, or other qualified health provider with any questions regarding a medical condition, and never disregard or delay seeking professional medical advice because of something you saw in the App.
18. License Grant
Subject to your compliance with these terms, we grant you a limited, non-exclusive, non-transferable, non-sublicensable, revocable license to download, install, and use GlucoRelay on any Apple device that you own or control, solely for your personal, non-commercial use as a secondary display of CGM data.
This license is also governed by the Apple Licensed Application End User License Agreement (EULA), which is incorporated into these terms by reference. For TestFlight builds, Apple's TestFlight terms also apply.
19. Restrictions
You agree not to:
- Copy, modify, distribute, sell, lease, sublicense, or create derivative works based on the App.
- Reverse-engineer, decompile, disassemble, or attempt to extract the source code of the App.
- Remove, alter, or obscure any copyright, trademark, or proprietary notices.
- Use the App for any unlawful purpose or in violation of any applicable laws or regulations.
- Use the App to access a CGM account or Nightscout server you are not authorized to access.
- Market, represent, or rely on the App as a medical device, clinical tool, or emergency service.
- Exploit the App or any part of it for commercial purposes without our prior written consent.
- Attempt to interfere with or disrupt the integrity of the App or its data storage systems.
20. Third-Party Services, Credentials & Trademarks
GlucoRelay connects to CGM manufacturers' cloud services (and, if you configure one, your own Nightscout server) using your own credentials, at your own direction and at your own risk. You represent that you are authorized to use those credentials and that your use of each service complies with that service's own terms. Those services may change, restrict, rate-limit, or break their interfaces at any time without notice to us or to you, and the App's connection to them may stop working as a result. We may, but are not obligated to, update the App to restore compatibility.
GlucoRelay is an independent app. It is NOT affiliated with, endorsed by, or sponsored by Dexcom, Abbott, Medtronic, Medtrum, Nightscout, or any CGM manufacturer or service. Dexcom, FreeStyle Libre, LibreLinkUp, CareLink, EasyView, and all other product and company names are trademarks of their respective owners, used here only to identify the services the App can read from.
21. Follower Sharing Terms
Follower Sharing is an optional feature that you, and only you, initiate — at your own discretion and at your own risk. You are responsible for deciding whom to give your share code to and for keeping it secret. Followers' displays are secondary displays too: they are subject to the same best-effort limitations described in Sections 13 and 14, and a follower must never rely on shared readings for treatment decisions or safety alerts. If you allow someone to follow readings, you should make sure they understand these limitations.
22. Beta Software (TestFlight)
GlucoRelay is currently distributed through Apple TestFlight as beta software. You acknowledge that beta software is provided for testing purposes, may contain defects or errors, may not perform as intended, may change significantly between builds, and may be suspended or discontinued at any time without notice. Settings, preferences, or data created while using a beta build may be lost when a build expires, is updated, or is removed. The best-effort nature of alerts described in Section 14 applies with even greater force to beta builds.
23. Intellectual Property
All rights, title, and interest in and to GlucoRelay — including but not limited to the software code, visual design, user interface elements, graphics, animations, icons, and documentation — are and shall remain the exclusive property of Approve The Move.
The name "GlucoRelay", the Approve The Move name and logo, and all associated branding are trademarks of Approve The Move. Nothing in these terms grants you any right to use our trademarks without prior written permission. Third-party trademarks are addressed in Section 20.
24. Disclaimer of Warranties
TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, THE APP IS PROVIDED "AS IS" AND "AS AVAILABLE", WITH ALL FAULTS AND WITHOUT WARRANTY OF ANY KIND, AND WE DISCLAIM ALL WARRANTIES, WHETHER EXPRESS, IMPLIED, OR STATUTORY.
This disclaimer includes, without limitation:
- Implied warranties of merchantability, fitness for a particular purpose, title, non-infringement, quiet enjoyment, and accuracy, and any warranties arising from course of dealing or usage of trade.
- Any warranty that the App will be uninterrupted, timely, error-free, secure, or free of viruses or other harmful components.
- Any warranty regarding the accuracy, timeliness, reliability, or completeness of glucose readings, trends, device status, or any other data displayed by the App.
- Any warranty that notifications or alerts will be delivered at all, or delivered on time (see Section 14).
- Any warranty that third-party CGM services, Nightscout servers, CloudKit, or Apple platform services will remain available or compatible.
No oral or written information or advice given by us or on our behalf creates any warranty. Some jurisdictions do not allow the exclusion of certain warranties, so some of the above exclusions may not apply to you; in that case, any non-excludable warranties are limited to the minimum scope and duration permitted by applicable law.
25. Limitation of Liability
TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL APPROVE THE MOVE OR ANY OF ITS AFFILIATES, OFFICERS, DIRECTORS, EMPLOYEES, CONTRACTORS, AGENTS, OR LICENSORS BE LIABLE FOR ANY:
- Indirect, incidental, special, consequential, punitive, or exemplary damages;
- Loss of data, profits, revenue, goodwill, anticipated savings, or other intangible losses;
- Personal injury or health consequences, to the extent such exclusion is permitted by applicable law, arising from reliance on the App contrary to Sections 13–17;
- Damages arising from your use of or inability to use the App;
- Damages arising from delayed, missing, or inaccurate readings, alerts, or notifications;
- Damages arising from the acts, omissions, outages, or changes of any third-party service (including CGM providers, Nightscout servers, CloudKit, and Apple platform services);
- Damages arising from treatment or health decisions made based on data displayed by the App;
- Any other damages arising out of or in connection with these terms or the App;
regardless of the theory of liability (contract, tort including negligence, strict liability, or otherwise), even if we have been advised of the possibility of such damages, and even if a limited remedy set out in these terms is found to have failed of its essential purpose.
To the maximum extent permitted by applicable law, our total aggregate liability arising out of or relating to the App or these terms shall not exceed the greater of (a) the amount you paid us for the App in the twelve (12) months preceding the claim (which, for this free app, is zero) and (b) ten United States dollars (USD 10).
Some jurisdictions do not allow the exclusion or limitation of liability for certain damages (including, in some places, personal injury or death caused by negligence), so some of the above limitations may not apply to you. In those jurisdictions, our liability is limited to the maximum extent permitted by applicable law.
26. Indemnification
To the maximum extent permitted by applicable law, you agree to indemnify, defend, and hold harmless Approve The Move and its officers, directors, employees, contractors, agents, licensors, and suppliers from and against any and all claims, liabilities, damages, losses, costs, and expenses (including reasonable attorneys' fees) arising out of or related to:
- Your misuse of the App, including any use contrary to Sections 13–17;
- Your violation of these Terms of Use or of any applicable law or regulation;
- Your infringement of any third-party rights;
- Your use of third-party credentials or services through the App, including access to any CGM account or Nightscout server;
- Your sharing of glucose data with followers, and any claims by or relating to your followers.
27. Force Majeure
To the maximum extent permitted by applicable law, we shall not be liable for any failure or delay in the App's operation caused by events beyond our reasonable control, including but not limited to: outages, changes, or discontinuation of third-party APIs or cloud services (including CGM providers' services and Apple's CloudKit); Apple platform or iOS restrictions and changes; network or internet failures; power failures; acts of God; natural disasters; epidemics; war; civil unrest; labor disputes; or governmental actions.
28. Governing Law & Dispute Resolution
These terms shall be governed by and construed in accordance with the laws of the State of Qatar, without regard to its conflict of law provisions.
Any dispute, controversy, or claim arising out of or relating to these terms or the App shall be resolved as follows:
- Informal resolution first — You agree to first attempt to resolve any dispute informally by contacting us at support@approvethemove.com. We will attempt to resolve the dispute within 30 days.
- Courts of Qatar — To the extent permitted by applicable law, any dispute not resolved informally shall be submitted to the exclusive jurisdiction of the competent courts of the State of Qatar.
Nothing in this section shall prevent either party from seeking injunctive or equitable relief from a court of competent jurisdiction to prevent the actual or threatened infringement of intellectual property rights.
Consumer forum rights: If the mandatory consumer protection laws of your country of residence grant you the right to bring or defend proceedings before the courts of your home jurisdiction (as, for example, Regulation (EU) No 1215/2012 does for EU/EEA residents), nothing in this section deprives you of that right.
29. Termination
These terms are effective until terminated. Your rights under these terms will terminate automatically and without notice if you fail to comply with any provision.
Upon termination, you must cease all use of the App and delete all copies from your devices. Sections 13 through 17 and 23 through 34 shall survive any termination of these terms.
We reserve the right to modify, suspend, or discontinue the App (or any part thereof) at any time without notice or liability.
30. Severability
If any provision of these terms is found to be unlawful, void, or unenforceable by a court of competent jurisdiction, that provision shall be deemed severable and shall not affect the validity and enforceability of the remaining provisions, which shall continue in full force and effect.
31. No Waiver
Our failure to enforce any right or provision of these terms shall not constitute a waiver of that right or provision. Any waiver must be in writing to be effective.
32. Assignment
We may assign or transfer these terms, in whole or in part, in connection with a reorganization, transfer of the App, or similar event. You may not assign or transfer these terms or any rights under them without our prior written consent, and any attempted assignment in violation of this section is void.
33. Consumer Rights
Nothing in these terms excludes, restricts, or modifies any statutory consumer right, guarantee, or remedy that applicable law does not allow to be excluded, restricted, or modified. Where such non-waivable rights apply, the disclaimers, limitations, and exclusions in these terms apply only to the maximum extent permitted by that law.
34. Entire Agreement
These terms, together with the Privacy Policy above and Apple's Licensed Application EULA (and, for beta builds, Apple's TestFlight terms), constitute the entire agreement between you and Approve The Move regarding your use of GlucoRelay. These terms supersede any prior agreements, communications, or understandings, whether written or oral, relating to the App.
General
35. Changes to This Document
We may update this Privacy Policy and Terms of Use from time to time to reflect changes in the App, our practices, or applicable laws. When we make changes:
- We will update the "Last updated" date at the top of this page.
- For material changes, we will notify you through the App before the changes take effect.
- The updated document will be posted at this URL: approvethemove.com/GlucoRelay/privacy.html
Your continued use of the App after changes are posted constitutes acceptance of the updated terms. If you disagree with any changes, your sole remedy is to stop using the App and delete it from your device.
36. Contact Us
If you have any questions, concerns, complaints, or requests regarding this Privacy Policy, these Terms of Use, or our practices, please contact us:
- Email: support@approvethemove.com
- Organization: Approve The Move
- Website: approvethemove.com
We commit to responding to all privacy-related inquiries within 30 days of receipt. For GDPR-related requests, we will respond within the legally required timeframe of one calendar month.